Bellerophon Therapeutics (BLPH) Prices 5M Common IPO at $12/Share

Bellerophon Therapeutics (Nasdaq: BLPH) announced the pricing of its initial public offering of 5,000,000 shares of common stock at a public offering price of $12.00 per share, before underwriting discounts. All of the shares in the offering are being sold by Bellerophon. In addition, Bellerophon has granted the underwriters an option to purchase up to 750,000 additional shares of common stock at the public offering price, less the underwriting discount. Bellerophon's common stock has been approved for listing on the NASDAQ Global Market and is expected to begin trading under the ticker symbol "BLPH" on February 13, 2015. The offering is expected to close on February 19, 2015, subject to customary closing conditions.

Leerink Partners LLC and Cowen and Company, LLC are acting as joint book-running managers for the offering. SunTrust Robinson Humphrey, Inc. and FBR Capital Markets & Co. are acting as co-managers.

You May Also Be Interested In

• Veg House Holdings (VEG) Announces 1M Share IPO at $5/sh
• Rubrik (RBRK) Prices 23M Share IPO at $32/sh, Above Indicated $28-$31/sh Range - Reuters
• Bristol-Myers Squibb (BMY) stock slips despite earnings beat